Brazil Cardiac Resynchronization Therapy Market valued at $120 Mn in 2022, projected to reach $191 Mn by 2030 with a 6% CAGR. The global rise in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a key factor contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, leading participants in this market include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.
Brazil Cardiac Arrhythmia Therapeutics Market valued at $180 Mn in 2022, projected to reach $305 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the rising burden of cardiac conditions, technological advancements, and growing healthcare expenditure. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, Biolab Sanus, Johnson & Johnson, and Boston Scientific among others.
The Brazil Kidney Cancer Therapeutics Market was valued at $157.25 Mn in 2023 and is predicted to grow at a CAGR of 5.86% from 2023 to 2030, to $234.27 Mn by 2030. Brazil Kidney Cancer Therapeutics Market is growing due to an Increase in Geriatric Population, a Rise in Lifestyle disorders, and Growing Pipeline of Novel Therapies. Amgen Inc., Bayer AG, F. Hoffmann-La Roche, Bristol Myers Squibb, and Abbott Laboratories are the major companies operating in the Brazil Kidney Cancer Therapeutics Market.
Brazil LASIK Surgery Market was valued at $88.25 Mn in 2023 and is predicted to grow at a CAGR of 6.21% from 2023 to 2030, to $134.55 Mn by 2030. The key drivers of this industry include rising prevalence, evolving consumer habits, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
The Brazil Medical Digital Imaging System Market was valued at $762.50 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $1411.88 Mn by 2030. The key drivers of this industry include healthcare spending, technological advancements, and rising chronic diseases. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Brazil Hemodialysis Vascular Grafts Market was valued at $5.24 Bn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $7.93 Bn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, the growing geriatric population, and government investment in healthcare. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Brazil Breastfeeding Accessories Market was valued at $62.75 Mn in 2023 and is predicted to grow at a CAGR of 7.80% from 2023 to 2030, to $106.16 Mn by 2030. The key drivers of this industry include early disease detection, personalized medicine, and government funding. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The Brazil Hospital Market was valued at $137.49 Bn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $244.95 Bn by 2030. The key drivers of this industry are rise in the geriatric population, technological advancement, and government initiatives. The key players in the industry are Hospital São Rafael, Rede D'Or São Luiz, Hospital Alemão Oswaldo Cruz, and Hospital Samaritano among others.
The Brazil Hemodialysis Equipment Market was valued at $353 Mn in 2023 and is projected to grow at a CAGR of 8.6% from 2023 to 2023, to $628.9 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Dialife, Renaltech, Biomed, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic Ltd among others.